Aterian Reports Fourth Quarter & Full Year 2022 Results
March 09, 2023 16:15 ET
|
Aterian, Inc
Achieved Substantial Progress Selling Through High Cost Inventory to Drive Margin Expansion Starting In the First Quarter of 2023 Reaffirms Second Half 2023 Adjusted EBITDA Profitability Target ...
Aterian Reports First Quarter 2022 Results
May 09, 2022 16:15 ET
|
Aterian, Inc
Reports First Quarter 2022 Net Revenue of $41.7 Million First Quarter Cash Balance of $44.3 Million NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the...
ARKO Corp. Set to Join Russell 2000 Index
June 16, 2021 07:00 ET
|
ARKO Corp.
RICHMOND, Va., June 16, 2021 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a growing leader in the U.S. convenience store industry, is set to join the broad-market Russell...
Aterian Announces Addition To The Russell 2000 Index
June 14, 2021 10:38 ET
|
Aterian, Inc.
NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) announced today that it is set to join the small-cap Russell 2000 Index and broad-market Russell...
Kinnate Biopharma Inc. Announces Its Addition to the Russell 2000® Index
March 19, 2021 16:05 ET
|
Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, March 19, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...